Showing results (21-30 of 214) with videos related to
Sort By:
Pageof 22
Blood|October 4, 2019
IL-6 dysregulation originates in dendritic cells and mediates graft-versus-host disease via classical signalingAndrew N Wilkinson, Karshing Chang, Rachel D Kuns, et al.Current Opinion in Immunology|October 11, 2025
Optimizing post-transplantation cell therapies to enhance graft-versus-leukemia effects in hematological malignanciesSimone A Minnie, Melissa M Berrien-Elliott, Melody Smith, et al.Blood|January 31, 2024
Regulatory T cells suppress myeloma-specific immunity during autologous stem cell mobilization and transplantationShuichiro Takahashi, Simone A Minnie, Kathleen S Ensbey, et al.Blood|February 20, 2025
Defining pathogenic IL-17 and CSF-1 gene expression signatures in chronic graft-versus-host diseaseJulie R Boiko, Kathleen S Ensbey, Olivia G Waltner, et al.Nature Reviews. Clinical Oncology|April 22, 2020
Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHDBruce R Blazar, Geoffrey R Hill, William J MurphyFrontiers in Immunology|May 6, 2016
Functional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell TransplantationMd Ashik Ullah, Geoffrey R Hill, Siok-Keen TeyEuropean Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|July 31, 2019
Adult related haematopoietic stem cell donor care: Views of Transplant NursesNienke Zomerdijk, Jane Turner, Geoffrey R Hill, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 20, 2020
Experiences and unmet needs of family members requested to donate haematopoietic stem cells to an ill relative: findings from a prospective multi-centre studyNienke Zomerdijk, Jane Turner, Geoffrey R Hill, et al.The Journal of Clinical Investigation|July 1, 2017
Cytokine mediators of chronic graft-versus-host diseaseKelli Pa MacDonald, Bruce R Blazar, Geoffrey R HillBlood|November 22, 2024
The contribution of the monocyte-macrophage lineage to immunotherapy outcomesRachael C Adams, Kelli P A MacDonald, Geoffrey R HillPageof 22